T. Rowe Price Associates
CORZ icon

T. Rowe Price Associates’s Core Scientific CORZ Stock Holding History

T. Rowe Price Associates’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Buy
706,695
+54,470
+8% +$929K ﹤0.01% 1204
2025
Q4 		$9.5M Sell
652,225
-3,705,717
-85% -$64.6M ﹤0.01% 1243
2025
Q3 		$78.2M Buy
4,357,942
+4,123,005
+1,755% +$60.5M 0.01% 675
2025
Q2 		$4.01M Buy
234,937
+58,962
+34% +$590K ﹤0.01% 1343
2025
Q1 		$1.27M Buy
175,975
+20,058
+13% +$228K ﹤0.01% 1825
2024
Q4 		$2.19M Buy
155,917
+50,758
+48% +$750K ﹤0.01% 1605
2024
Q3 		$1.25M Buy
105,159
+48,463
+85% +$502K ﹤0.01% 1877
2024
Q2 		$0 Buy
+56,696
New +$290K ﹤0.01% 2943

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

T. Rowe Price Associates's CORZ Position: Q1 2026 in Review

T. Rowe Price Associates increased its Core Scientific (CORZ) stake by 8.4% in Q1 2026, buying an estimated $929K and bringing the position to 706,695 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1204.

T. Rowe Price Associates first reported a position in CORZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $78.2M in Q3 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • T. Rowe Price Associates held 706,695 shares of Core Scientific worth $10.6M as of Q1 2026.
  • T. Rowe Price Associates bought 54,470 Core Scientific shares in Q1 2026, an estimated $929K.
  • Core Scientific made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1204 holding.
  • T. Rowe Price Associates first reported a position in Core Scientific in Q2 2024 and has held it in 8 quarters since.
  • T. Rowe Price Associates's Core Scientific position peaked at $78.2M in Q3 2025.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.